Your Placenta is more abundant and powerful than you ever thought


"The placenta is the least understood human organ, but arguably one of the most important. It influences not just the health of a woman and her fetus during pregnancy, but also the lifelong health of both" NIH - THE HUMAN PLACENTA PROJECT
AmnioChor seeks to change the placenta's paradigm from medical waste to medical wonder, and begin its' second, and everlasting life after childbirth.
Your Placenta
Amniotic Membrane of the Placenta
AmnioChor believes that the Amniotic Membrane of the Placenta is at the center of the perinatal universe and cellular therapy potential.



OmniBank
AmnioChor's mission is to build the first Biobank that can benefit the entire population. The OmniBank will preserve the highest quality placental tissue for Stem Cell and EV production

Amnion-derived Stem Cells isolated and cryopreserved by AmnioChor's proprietary non-enzymatic process. The PLURINATAL process avoids animal products, minimizes metabolic stress on the cells, presents less surface/ECM damage, and affords improved viability.
AC26
Immediate placenta life support, preservation, and transport device to insure maximum tissue, cell, and blood preservation.
Zero G (pba1)
Cryopreservation of the Amniotic Membrane of the Placenta at birth in AmnioChor's fee-based Personal bank, or free community bank where everyone will soon have an opportunity to participate.
OmniBank
OB-Now is an app in development to become a digital conduit between mom & dad, healthcare and AmnioChor. It will offer pregnancy guidance and wellness information, through OmniBank membership.
OB-now
Tissue retrieval, processing and cryopreservation device. The AmnioCept brings AmnioChor's Plurinatal process to life by allowing for the creation of multiple independent tissue samples for maximum cell production.
AmnioCept
AmnioChor's laboratory benchtop rapid tissue explant bioreactor for the production of ADSCs (Amnion-derived Stem Cells), and conditioned media.
TexBIO
A unique placental tissue sampling device
Cutlass
Products in Development
Your Placenta Your Future


Strategy
Based on HLA tissue-typing, the valuable biological components of the Amniotic Membrane will be best suited for Allogeneic, Matched Allogeneic and/or Autologous therapies
Execution
Parents will be afforded the opportunity to join the OmniBank Personal banking program and cryopreserve multiple samples for future autologous therapeutic needs. Or parents will have the option to donate their placenta and a portion of their tissue samples and participate in the OmniBank Community banking program for other future benefits.
